The Food and Drug Administration (FDA) approved Xeomin in July 2011 for the treatment of severe frown lines or “11’s” between the eyes.XEOMIN® (incobotulinumtoxinA) is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
IncobotulinumtoxinA is made from the bacteria that causes botulism. Botulinum toxin blocks nerve activity in the muscles, causing a temporary reduction in muscle activity.
Typically Xeomin takes 2-3 days after injection. Effectiveness of product last 4 months.